Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma
- PMID: 20403855
- DOI: 10.1001/archoto.2010.40
Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma
Abstract
Objective: To determine the feasibility of robotic-assisted salvage surgery for oropharyngeal cancer.
Design: Retrospective case-controlled study.
Setting: Academic, tertiary referral center.
Patients: Patients who underwent surgical resection for T1 and T2 oropharyngeal cancer between 2001 and 2008 were classified into the following 3 groups based on type of resection: (1) robotic-assisted surgery for primary neoplasms (robotic primary) (n = 15), (2) robotic-assisted salvage surgery for recurrent disease (robotic salvage) (n = 7), and (3) open salvage resection for recurrent disease (n = 14).
Main outcome measures: Data regarding tumor subsite, stage, and prior treatment were evaluated as well as margin status, nodal disease, length of hospital stay, diet, and tracheotomy tube dependence.
Results: The median length of stay in the open salvage group was longer (8.2 days) than robotic salvage (5.0 days) (P = .14) and robotic primary (1.5 days) resection groups (P < .001). There was no difference in postoperative diet between robotic primary and robotic salvage surgery groups. However, a greater proportion of patients who underwent open salvage procedures were gastrostomy tube dependent 6 months following treatment (43%) compared with robotic salvage resection (0%) (P = .06). A greater proportion of patients who underwent open salvage procedures also remained tracheotomy tube dependent after 6 months (7%) compared with robotic salvage or robotic primary patients (0%) (P = .48). No complications were reported in the robotic salvage group. Two patients who underwent open salvage resection developed postoperative hematomas and 2 developed wound infections.
Conclusion: When feasible, robotic-assisted surgery is an acceptable procedure for resection of both primary and recurrent oropharyngeal tumors. Trial Registration clinicaltrials.gov Identifier: NCT00473564.
Comment in
-
Transoral robotic surgery: disruptive or sustaining innovation?Arch Surg. 2010 Sep;145(9):907-8. doi: 10.1001/archsurg.2010.173. Arch Surg. 2010. PMID: 20855763 No abstract available.
Similar articles
-
Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.JAMA Otolaryngol Head Neck Surg. 2013 Aug 1;139(8):773-8. doi: 10.1001/jamaoto.2013.3866. JAMA Otolaryngol Head Neck Surg. 2013. PMID: 23949352
-
Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma.Arch Otolaryngol Head Neck Surg. 2011 Nov;137(11):1112-6. doi: 10.1001/archoto.2011.172. Arch Otolaryngol Head Neck Surg. 2011. PMID: 22106235
-
Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.Laryngoscope. 2010 Sep;120(9):1749-55. doi: 10.1002/lary.21021. Laryngoscope. 2010. PMID: 20717944
-
Survival outcomes following salvage surgery for oropharyngeal squamous cell carcinoma: systematic review.J Laryngol Otol. 2018 Apr;132(4):299-313. doi: 10.1017/S0022215117000998. Epub 2017 May 15. J Laryngol Otol. 2018. PMID: 28502256
-
Reoperative maxillofacial oncology.Oral Maxillofac Surg Clin North Am. 2011 Feb;23(1):161-8, vii. doi: 10.1016/j.coms.2010.11.002. Oral Maxillofac Surg Clin North Am. 2011. PMID: 21272772 Review.
Cited by
-
Current Advances in Robotics for Head and Neck Surgery-A Systematic Review.Cancers (Basel). 2021 Mar 19;13(6):1398. doi: 10.3390/cancers13061398. Cancers (Basel). 2021. PMID: 33808621 Free PMC article. Review.
-
Comparison of the effects of submucosal hyaluronidase and dexamethasone on postoperative edema, pain, trismus, and infection following impacted third molar surgery.BMC Oral Health. 2024 Aug 30;24(1):1018. doi: 10.1186/s12903-024-04729-1. BMC Oral Health. 2024. PMID: 39215323 Free PMC article. Clinical Trial.
-
A Comprehensive Systematic Review on Functional Results, Speech and Swallowing Outcomes after Trans-Oral Robotic Surgery for Oropharyngeal Squamous Cell Cancer.J Clin Med. 2024 Oct 10;13(20):6039. doi: 10.3390/jcm13206039. J Clin Med. 2024. PMID: 39457989 Free PMC article. Review.
-
Transoral robotic surgery and intensity-modulated radiotherapy in the treatment of the oropharyngeal carcinoma: a systematic review and meta-analysis.Eur Arch Otorhinolaryngol. 2021 May;278(5):1321-1335. doi: 10.1007/s00405-020-06224-z. Epub 2020 Jul 21. Eur Arch Otorhinolaryngol. 2021. PMID: 32696250
-
Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma.JAMA Oncol. 2020 Oct 1;6(10):1555-1562. doi: 10.1001/jamaoncol.2020.3172. JAMA Oncol. 2020. PMID: 32816023 Free PMC article.
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical